MedTrace Logo

The Cirrhosis Outpatient Optimization, Readmission & Safety Study

NCT02457988 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-12-22

No results posted yet for this study

Summary

A prospective series comparing care incorporating home monitoring and liver care coordination to conventional care for patients with cirrhosis.

Conditions

  • Cirrhosis

Interventions

DEVICE

Vivify Kit

home telemonitoring devices with vital sign capturing capabilities, i.e. blood pressure, weight, pulse, and specific questionnaires targeted to the cirrhosis diagnosis.

Sponsors & Collaborators

Principal Investigators

  • Daniel W Hommes, MD, PhD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02457988 on ClinicalTrials.gov